- 06:59 PM Immediate supports for rupee at 46.20/46.10: Commt...
- 06:52 PM FIIs net sell Rs 68 cr in equities on Nov 23
- 06:38 PM Buy Unity Infra: target of Rs 605: India Capital M...
- 06:38 PM Godrej Group puts two brands on the block
- 06:26 PM Mkts consolidates after 2 days of strong rally: Ni...
- 06:25 PM Karvy negative on telecom sector
- 06:24 PM Air India saves Rs 400cr through restructuring
- 06:11 PM Unitech gears up for thrid fund raising exercise
- 06:11 PM RIL rangebound between Rs 1,900-2,200: Gujral
- 06:11 PM Reliance reopens 900 gas stations: Official
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted approval for the Abbreviated New Drug Application (ANDA) to market a generic version of Forest Lab’s Tessalon®, benzonatate capsules.
Benzonatate USP capsules are therapeutically equivalent to Forest Lab’s Tessalon®, and are available in two strengths: capsules containing 100 mg and 200 mg benzonatate USP.
Benzonatate has annual sales of approximately USD 40 million in the US.
Benzonatate is an antitussive, used to relieve cough due to the common cold, bronchitis, pneumonia, or other lung infections.
This product will reach market shortly.
Sourced From: Sun Pharmaceutical Industries Ltd
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- Mitesh Thacker's top 5 picks for trade today
- Ganeshaspeaks: Market prediction for Nov 24
- Den Networks slips 22% after listing at Rs 195
- Trading in MF units to start in 15 days: SEBI
- Will ITC dream run continue beyond FY10?
- Why LyondellBasell is a goldmine for RIL
- Experts see mkts at new highs, advise sectors
- Corrections in '10 to be more aggressive, violent: JPMorgan
- Mahindra may increase car prices due to rising input costs
Source: Business Line
- Renault to continue with M&M for Logan, says Ghosn
Source: Business Line
- Market volatility poses valuation problems: IRDA
Source: Business Line
- Punjab, Haryana buck all-India rice decline trend
Source: Business Line
